Funding for new medical ventures improving

NewsGuard 100/100 Score
The Dallas Morning News reports on the funding climate for health care technology startups.

At the second annual MedVentures conference, "the consensus of entrepreneurs … is that the fundraising climate is getting better after a rough few years, but there's still a dearth of seed and start-up money. Venture capital investments in biotechnology and medical devices ... peaked in 2007 and hit a low point in early 2009. But funding for the first half of this year is increasing. For the Dallas area, venture capitalists invested $12.1 million in life sciences in the first half of this year compared with nothing at all last year, according to data from PricewaterhouseCoopers. Statewide, life sciences raised $57.2 million, beating the $9.4 million for the first half of 2009. Nationally, biotechnology raised the most money of any industry in the first half of 2010 - $2.1 billion, up 31 percent from a year ago" (Jean, 7/22).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New tARC-seq method enhances precision in tracking SARS-CoV-2 mutations